Clinical Trial 23775

• Overview

  Study Title:

  A Phase 2a Study of High Dose Testosterone followed by Targeted Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer

• Treatments

  Therapies:

  Androgen deprivation therapy (ADT); Hormone replacement therapy; Targeted radioligand therapy

  Medications:

  Decapeptyl SR (Triptorelin); Degarelix (); Eligard (Leuprolide); Leuprolide (); Luteinizing hormone-releasing hormone (LHRH) analog (); PSMA-617 (); Relugolix (Orgovyx); Testosterone cypionate (); Triptorelin ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.